Stem cell hierarchies and developmental origins of rhabdomyosarcoma
- Yun Wei1
- Qian Qin1
- Chuan Yan1
- Madeline N. Hayes1
- Sara P. Garcia1
- Haibin Xi2
- Daniel Do1
- Alexander H. Jin1
- Tiffany Eng1
- Karin M. McCarthy1
- Abhinav Adhikari1
- Maristela L. Onozato1
- Dimitrios Spentzos3
- Gunnlaugur P. Neilsen3
- A. John Iafrate1
- Leonard H. Wexler4
- April D. Pyle2
- Mario L. Suvà1
- Filemon Dela Cruz4
- Luca Pinello1
- David M. Langenau1
- 1. Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, MA 02129
- 2. Department of Microbiology, Immunology, and Molecular Genetics; University of California Los Angeles, Los Angeles, CA 90095
- 3. Center for Sarcoma and Connective Tissue Oncology, Department of Orthopedic Surgery, Massachusetts General Hospital, Boston, MA, 02114
- 4. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065
Description
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood and is comprised of two major molecular subtypes. Despite sharing features with skeletal muscle, the conservation of underlying cellular hierarchy with human muscle development and the identification of molecularly-defined tumor-propagating cells have not been reported. Using single-cell RNA sequencing of patient-derived RMS, DNA-barcode cell fate mapping, and antibody enrichment and functional stem cell assays using in vitro culture and mouse xenografts, we have uncovered tumor cell hierarchies in Fusion-negative (FN-) RMS that are shared with normal human muscle development. We also identified common developmental stages at which tumor cells become arrested. FN-RMS resemble early muscle found in embryonic and larval development, while fusion-positive (FP-)RMS express a highly specific developmental gene program found in muscle cells transiting from embryonic to fetal development at 7-7.75 weeks of age. FP-RMS also have neural-pathway enriched cell states, suggesting less-rigid adherence to muscle development hierarchies in this disease. Finally, we identify a molecularly-defined tumor-propagating cell in FN-RMS that shares remarkable similarity to the newly described bi-potent, muscle mesenchyme stem/progenitor cell that makes both muscle and osteogenic cells.